The Neuropathology group, led by Dr. Michel Mittelbronn, is a translational group linking clinico-diagnostic neuropathological research (at the Laboratoire national de Santé (LNS) in Dudelange) with basic neurooncological (at the Luxembourg Institute of Health (LIH) in Luxembourg) as well as neurodegenerative (at the LCSB) research supported by the FNR PEARL programme. The overarching goal is to translate clinico-pathological findings into cell culture- and animal-based experimental laboratory models and to validate basic research findings in patient cohorts. With this approach, we aim at deciphering the pathogenesis of neurological disorders as well as translate basic laboratory findings into diagnostic and therapeutic applications.